Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Crypt Organoid Culture as an in Vitro Model in Drug Metabolism and Cytotoxicity Studies.

Lu W, Rettenmeier E, Paszek M, Yueh MF, Tukey RH, Trottier J, Barbier O, Chen S.

Drug Metab Dispos. 2017 Jul;45(7):748-754. doi: 10.1124/dmd.117.075945. Epub 2017 May 3.

2.

Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia.

Yueh MF, Chen S, Nguyen N, Tukey RH.

Mol Pharmacol. 2017 May;91(5):545-553. doi: 10.1124/mol.116.107524. Epub 2017 Mar 10. Review.

3.

Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia.

Chen S, Lu W, Yueh MF, Rettenmeier E, Liu M, Paszek M, Auwerx J, Yu RT, Evans RM, Wang K, Karin M, Tukey RH.

Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1432-E1440. doi: 10.1073/pnas.1700232114. Epub 2017 Feb 6. Erratum in: Proc Natl Acad Sci U S A. 2017 May 16;114(20):E4115. Paszek, Miles [added].

4.

Cadmium and arsenic override NF-κB developmental regulation of the intestinal UGT1A1 gene and control of hyperbilirubinemia.

Liu M, Chen S, Yueh MF, Fujiwara R, Konopnicki C, Hao H, Tukey RH.

Biochem Pharmacol. 2016 Jun 15;110-111:37-46. doi: 10.1016/j.bcp.2016.04.003. Epub 2016 Apr 6.

5.

Reduction of p53 by knockdown of the UGT1 locus in colon epithelial cells causes an increase in tumorigenesis.

Liu M, Chen S, Yueh MF, Wang G, Hao H, Tukey RH.

Cell Mol Gastroenterol Hepatol. 2016 Jan;2(1):63-76.e5. Epub 2015 Oct 13.

6.

Triclosan: A Widespread Environmental Toxicant with Many Biological Effects.

Yueh MF, Tukey RH.

Annu Rev Pharmacol Toxicol. 2016;56:251-72. doi: 10.1146/annurev-pharmtox-010715-103417. Review.

7.

Reduced Myelination and Increased Glia Reactivity Resulting from Severe Neonatal Hyperbilirubinemia.

Barateiro A, Chen S, Yueh MF, Fernandes A, Domingues HS, Relvas J, Barbier O, Nguyen N, Tukey RH, Brites D.

Mol Pharmacol. 2016 Jan;89(1):84-93. doi: 10.1124/mol.115.098228. Epub 2015 Oct 19.

8.

The commonly used antimicrobial additive triclosan is a liver tumor promoter.

Yueh MF, Taniguchi K, Chen S, Evans RM, Hammock BD, Karin M, Tukey RH.

Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17200-5. doi: 10.1073/pnas.1419119111. Epub 2014 Nov 17.

9.

Developmental onset of bilirubin-induced neurotoxicity involves Toll-like receptor 2-dependent signaling in humanized UDP-glucuronosyltransferase1 mice.

Yueh MF, Chen S, Nguyen N, Tukey RH.

J Biol Chem. 2014 Feb 21;289(8):4699-709. doi: 10.1074/jbc.M113.518613. Epub 2014 Jan 8.

10.

Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11).

Chen S, Yueh MF, Bigo C, Barbier O, Wang K, Karin M, Nguyen N, Tukey RH.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19143-8. doi: 10.1073/pnas.1319123110. Epub 2013 Nov 4.

11.

Triclocarban mediates induction of xenobiotic metabolism through activation of the constitutive androstane receptor and the estrogen receptor alpha.

Yueh MF, Li T, Evans RM, Hammock B, Tukey RH.

PLoS One. 2012;7(6):e37705. doi: 10.1371/journal.pone.0037705. Epub 2012 Jun 15.

12.

Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice.

Chen S, Yueh MF, Evans RM, Tukey RH.

Hepatology. 2012 Aug;56(2):658-67. doi: 10.1002/hep.25671. Epub 2012 Jun 11.

13.

Inhibition of human UGT2B7 gene expression in transgenic mice by the constitutive androstane receptor.

Yueh MF, Mellon PL, Tukey RH.

Mol Pharmacol. 2011 Jun;79(6):1053-60. doi: 10.1124/mol.110.070649. Epub 2011 Mar 17.

14.

Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling.

Chouinard S, Yueh MF, Tukey RH, Giton F, Fiet J, Pelletier G, Barbier O, Bélanger A.

J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):247-53. doi: 10.1016/j.jsbmb.2008.03.016. Epub 2008 Mar 13.

PMID:
18467088
15.

Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice.

Yueh MF, Tukey RH.

J Biol Chem. 2007 Mar 23;282(12):8749-58. Epub 2007 Jan 26.

16.

Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation.

Senekeo-Effenberger K, Chen S, Brace-Sinnokrak E, Bonzo JA, Yueh MF, Argikar U, Kaeding J, Trottier J, Remmel RP, Ritter JK, Barbier O, Tukey RH.

Drug Metab Dispos. 2007 Mar;35(3):419-27. Epub 2006 Dec 6.

PMID:
17151188
17.

The role of Ah receptor in induction of human UDP-glucuronosyltransferase 1A1.

Yueh MF, Bonzo JA, Tukey RH.

Methods Enzymol. 2005;400:75-91.

PMID:
16399344
18.

A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.

Trubetskoy O, Marks B, Zielinski T, Yueh MF, Raucy J.

AAPS J. 2005 Mar 4;7(1):E6-13.

19.

Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes.

Yueh MF, Kawahara M, Raucy J.

Toxicol In Vitro. 2005 Mar;19(2):275-87.

PMID:
15649641
20.

High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line.

Yueh MF, Kawahara M, Raucy J.

Drug Metab Dispos. 2005 Jan;33(1):38-48. Epub 2004 Oct 1.

PMID:
15466163
21.

Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1.

Yueh MF, Huang YH, Hiller A, Chen S, Nguyen N, Tukey RH.

J Biol Chem. 2003 Apr 25;278(17):15001-6. Epub 2003 Feb 3.

22.

A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.

Raucy J, Warfe L, Yueh MF, Allen SW.

J Pharmacol Exp Ther. 2002 Oct;303(1):412-23.

PMID:
12235278
23.

Genetic polymorphisms of flavin-containing monooxygenase (FMO).

Krueger SK, Williams DE, Yueh MF, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.

Drug Metab Rev. 2002 Aug;34(3):523-32. Review.

PMID:
12214664
24.

Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits.

Larsen-Su SA, Krueger SK, Yueh MF, Pereira CB, Williams DE.

Biochem Pharmacol. 2002 Apr 1;63(7):1353-9.

PMID:
11960612
25.

Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.

Krueger SK, Martin SR, Yueh MF, Pereira CB, Williams DE.

Drug Metab Dispos. 2002 Jan;30(1):34-41.

PMID:
11744609
26.

The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines.

Yueh MF, Nguyen N, Famourzadeh M, Strassburg CP, Oda Y, Guengerich FP, Tukey RH.

Carcinogenesis. 2001 Jun;22(6):943-50.

PMID:
11375903
27.

Characterization of expressed full-length and truncated FMO2 from rhesus monkey.

Krueger SK, Yueh MF, Martin SR, Pereira CB, Williams DE.

Drug Metab Dispos. 2001 May;29(5):693-700.

PMID:
11302936
28.

Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: detection of expressed protein in African-Americans.

Whetstine JR, Yueh MF, McCarver DG, Williams DE, Park CS, Kang JH, Cha YN, Dolphin CT, Shephard EA, Phillips IR, Hines RN.

Toxicol Appl Pharmacol. 2000 Nov 1;168(3):216-24.

PMID:
11042094
29.

Flavin-containing monooxygenase isoform 2: developmental expression in fetal and neonatal rabbit lung.

Larsen-Su S, Krueger SK, Yueh MF, Lee MY, Shehin SE, Hines RN, Williams DE.

J Biochem Mol Toxicol. 1999;13(3-4):187-93.

PMID:
10098904
30.

Pulmonary flavin-containing monooxygenase (FMO) in rhesus macaque: expression of FMO2 protein, mRNA and analysis of the cDNA.

Yueh MF, Krueger SK, Williams DE.

Biochim Biophys Acta. 1997 Feb 28;1350(3):267-71.

PMID:
9061021
31.

Clinical correlations in HIV-1 and HIV-2 infected patients.

Monteiro-Grillo M, Sousa AP, Galvao J, Yueh M, Neves C, Ribeiro-da-Silva J.

Eur J Ophthalmol. 1993 Jan-Mar;3(1):13-20.

PMID:
8485393

Supplemental Content

Support Center